Patent · US Active

Allergen desensitization method

US11202826B2 · kind B2 · utility

2Cited by
57References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 23, 2020
Grant dateDec 21, 2021
Priority date
Expiry dateJul 23, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/545
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.